electromagnetic energies, obviating the need for mechanical cable connections. The potential to provide exact readings without the need for direct physical touch is essential for achieving ultrahigh sensitivity in detecting proteins in fluids utilizing gear constructed around quartz crystal biological sensors. Due to their unique properties, silica, quartz, and glass are used to develop cutting-edge biosensors. These biosensors use advanced technological advancements to enhance the efficacy of bio-instrumentation within the medical domain. However, it is crucial to address concerns about biological security and the associated financial implications [95].

fixed cells. Utilizing natural amino acids, small-molecular interactions with sub­stances, and additional messengers are unique approaches offered because of this approach, which has undoubtedly contributed to the development of sensors [99]. Recently, fluorescent biosensors have been developed that enable the analysis of motor proteins through single-molecule detection, which allows for the precise determination of analyte concentration. The technique that is used for probe identification and evaluation looks to present some difficulties, notwithstanding the benefits that have been discussed previously. The discovery of green fluorescent protein and other fluorescent proteins has yielded numerous benefits in optical probe design and efficiency. In the preceding decade, there has been significant progress in genetically encoded biosensors targeting chemicals associated with energy produc­tion, reactive oxygen species, and cyclic adenosine monophosphate (cAMP).

[102]. In a similar vein, researchers have devised microbial fuel-based biosensors with the objective of monitoring levels of biochemical oxygen demand and assessing toxicity within the surrounding environment. Bacterial organisms can break down organic substrates and produce electrical energy through fermentation. The tech­nology encompasses utilizing a bio-electrochemical apparatus that regulates the capacity of microbial respiration to transform organic substrates into electrical energy directly. Despite the potential advantages, microbial biosensors are con­strained by limits related to their low power density, which affects both production and operational costs. There is a current focus on improving performance and reducing costs through novel systemic approaches. These approaches leverage technologies to create self-powered engineered microbial biosensors, which hold promise for considerable advancements. Microbial biosensors have demonstrated promising applications in detecting pesticides and heavy metals [91]. Eukaryotic microorganisms possess certain advantages over prokaryotic cells in this area. The primary reason for developing whole-cell biosensors is their ability to detect heavy metal selectively and sensitively and pesticide toxicity.

processes that leverage contact and non-contact-based structuring approaches. Using nanoparticles such as gold-, silver-, and silicon-based biofabrication has developed novel methodologies. Furthermore, using polymer coatings on these nanoparticles has led to a significant breakthrough in contact-based electrochemical detecting. The first advantage associated with electrochemical sensors of this nature is their high sensitivity and specificity, enabling real-time examination [105]. Nevertheless, the regeneration capacity or long-term viability of polymers and other materials remains restricted. Nonetheless, the lower cost associated with these electrochemical sensors renders them more economically accessible. The utilization of contact-based sensing for single-analyte detection offers significant benefits, such as the ability to do real-time measurements of molecules with a high degree of specificity. Both the sensitivity and the specificity of single-compound recognition have been enhanced through the development of various transducers, such as FRET (fluorescence resonance energy transfer) and luminous resonating transmitting energy, fluorescent-based transducers, and surface-plasma resonator-based trans­ducers. Because of the overlap in the emitted signals, these methods are restricted in their ability to identify several analytes [106]. Nevertheless, resonance energy transfer techniques have often been used to detect numerous analytes. This is particularly valuable in clinical diagnosis due to the distinct biomarkers in patients and associated diseases. The use of micro- or nano-cantilevers as transducers in the biofabrication of electrochemical sensors shows promising prospects in identifying various analytes. Additionally, it has been noted that non-contact-based sensors using 3D bioprinting methods, such as inkjet or laser direct writing, provide improved results. However, these technologies have significant cost and custom­ization stability limits. It is worth noting that most of these high-throughput biosensors have been integrated with electrochemical sensing techniques for targeted applications. Several highly significant amperometry electrochemical biosensors, characterized by their sensitivity, real-time capabilities, and portability, have been successfully developed for the purpose of disease diagnosis through the analysis of bodily fluids [107]. Electrochemical biosensors, when utilized in conjunction with biofabrication techniques, have a notable advantage in detecting single analytes with high specificity, real-time analytical capabilities, and cost-effectiveness, hence facilitating device portability. Optical-based biosensors represent a significant advancement in the field of biosensing, namely in the domain of fiber-optic chemistry. Hydrogel-based cross-linking is the preferred method for detecting single molecules, such as DNA or peptides, owing to its advantageous characteristics of high loading capacity and hydrophilicity. Subsequent advancements in optical biosensor technology have yielded enhanced capabilities for DNA measurement, hence expanding its utilization in the fields of biomedicine and forensic research. The incorporation of biological constituents, including enzyme groups, antibody and antigen combinations, and nucleic acids, has brought about substantial advance­ments in the realm of optical biosensor technology [108]. In addition, the biosensing system may be expanded to include microorganisms, animal or plant cells, and tissue sections. Optical fingerprint recognition systems were made possible by recent

progress in molecular optoelectronics. The use of integrated optics technology allows for incorporating both passive and active optical components onto a single substrate, simplifying the development of compact sensing devices with diminished dimensions. This objective is accomplished by integrating several sensors onto a single microchip. In the present scenario, high-quality polymer compounds can fabricate hybrid assemblies for optical biosensors. Ongoing progress in surface anatomy studies has improved optic-based biosensor equipment using advanced methods like high-end electrons and atomic strength microscopy. Despite these factors, the detection limit of optical biosensors has not yet reached the femto level due to the high equipment cost and lack of device portability. To achieve this objective, recent advancements in optical technology have led to the development of nanomechanical biosensors that utilize microcantilevers and surface resonance technology [109]. These revolutionary biosensors have enabled the creation of DNA chips capable of conducting real-time analysis with high specificity and sensitivity. The advantages of optical biosensors primarily encompass rapid analysis, immunity to electrical or magnetic interference, and the ability to provide a wide range of information. However, a significant limitation of this approach is the substantial expense associated with specific instrumentation prerequisites. Additional challenges in optical biosensors include the complexity of immobiliza­tion, particularly in the context of biofabrication, as well as the crucial necessity for a sterile environment. These issues must be effectively addressed to fully harness the potential of optical biosensors. The utilization of biofabrication techniques in the development of mechanical devices yields superior outcomes in the context of mass­based biosensors. Both electrochemical and optical biosensors utilize this technology to develop advanced biosensors. Significant progress in micro- and nanofabrication technologies has facilitated mechanical devices’ emergence using nanoscale dimen­sions components [110]. The capacity to generate these structures by implementing semiconductor processing techniques has effectively merged the principles of biophysics and bioengineering, leading to advancements in the development of practical biosensors at the micro- and nano-electromechanical scale, which can be manufactured in significant quantities. Fluorescence or gold nanoparticles have effectively labeled glass, silicon, and quartz materials. While the precision of these biosensors in detecting single molecules is higher, the feasibility of low-cost mass production is limited. Numerous obstacles still need to be addressed in the field of mass-based sensors, particularly in developing improved capture agents that can be fabricated at the nanoscale utilizing microelectronic fabrication techniques. These advancements are crucial for enabling high-throughput analysis. It is noteworthy to underline the significant potential applications of semiconductor materials and quantum dot technologies in this context. Nevertheless, existing biosensor innova­tions exhibit a deficiency in their capacity to conduct quantitative trials concurrently and instantaneously for extensive panels. However, micro and nano cantilevered fabrication can provide like capability [111].

defense, and security domains. Integrating nanomaterials and polymers with diverse biosensors will yield hybrid devices with improved application functionality.

increased utilization of biosensors across multiple industries. In addition to widely utilized point-of-care equipment such as oximetry, pregnancy test strips, and glucose test strips, the market also offers continuous glucose monitoring systems. Biosensors have consistently exhibited efficacy in biological science and healthcare, owing to their appealing attributes, including notable sensitivity, exceptional specificity, convenient mobility, accessibility for end-users, prompt delivery of results, and compatibility with various technologies and devices [121]. The rapid expansion of the global biosensors market is primarily attributed to the enhanced functionality of biosensors and the escalating need for efficient and affordable point-of-care testing. Projections indicate a compound annual growth rate (CAGR) of 7.9% from 2021 to